Literature DB >> 5830803

Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA.

L S Seiden, L C Hanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1964        PMID： 5830803     DOI： 10.1007/BF00413153

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  13 in total

1.  Electrophysiological correlates of avoidance conditioning in the cat.

Authors:  E R JOHN; K F KILLAM
Journal:  J Pharmacol Exp Ther       Date:  1959-03       Impact factor: 4.030

2.  Antagonism of locomotor suppressant effects of reserpine in mice.

Authors:  C B SMITH; P B DEWS
Journal:  Psychopharmacologia       Date:  1962-03-12

3.  Central aromatic amine levels and behavior. I. Conditioned avoidance response in cats, following administration of psychoactive drugs or amine precursors.

Authors:  J A WADA; J WRINCH; D HILL; P L McGEER; E G McGEER
Journal:  Arch Neurol       Date:  1963-07

4.  In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Physiol Scand       Date:  1962-01

5.  On the distribution in brain of monoamines and of enzymes responsible for their formation.

Authors:  A BERTLER; E ROSENGREN
Journal:  Experientia       Date:  1959-10-15

6.  Occurrence and distribution of catechol amines in brain.

Authors:  A BERTLER; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1959-12-12

7.  The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors:  H BLASCHKO; T L CHRUSCIEL
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

8.  A method for the fluorimetric determination of adrenaline and noradrenaline in tissues.

Authors:  A BERTLER; A CARLSSON; E ROSENGREN
Journal:  Acta Physiol Scand       Date:  1958-12-15

9.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

10.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15
View more
  9 in total

1.  Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.

Authors:  Ming Li; Tao Sun; Chen Zhang; Gang Hu
Journal:  Psychopharmacology (Berl)       Date:  2010-07-10       Impact factor: 4.530

2.  Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  S Ahlenius; J Engel
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

3.  Effect of L-dopa on delayed response and visual discrimination in cats and its relation to brain chemistry.

Authors:  A Kitsikis; A G Roberge; G Frenette
Journal:  Exp Brain Res       Date:  1972       Impact factor: 1.972

4.  The use of extinction to investigate the nature of neuroleptic-induced avoidance deficits.

Authors:  R J Beninger; S T Mason; A G Phillips; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

5.  Central catecholamine neurons and conditioned avoidance behaviour.

Authors:  K Fuxe; C F Hanson
Journal:  Psychopharmacologia       Date:  1967-10-06

6.  Biochemical and behavioural effects of tyrosine hydroxylase inhibition.

Authors:  L C Hanson
Journal:  Psychopharmacologia       Date:  1967

7.  Effects of alpha-methyl-dopa on conditioned behaviour in the cat.

Authors:  L C Hanson; M Henning
Journal:  Psychopharmacologia       Date:  1967

8.  Genetic analysis of the behavioral response to d-amphetamine in mice.

Authors:  B Moisset
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

Review 9.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.